首页> 外国专利> Preparation method of prostate tumor-targeted double-regulated oncolytic adenovirus expressing superantigen gene

Preparation method of prostate tumor-targeted double-regulated oncolytic adenovirus expressing superantigen gene

机译:表达超抗原基因的前列腺肿瘤靶向双调控溶瘤腺病毒的制备方法

摘要

A prostate tumor targeted expression of a superantigen gene is provided, and more particularly, a preparation method of a prostate tumor-targeted double-regulated oncolytic adenovirus expressing a superantigen gene is provided, which belongs to the technical field of gene therapy. According to the preparation method, using the gene engineering technology, a staphylococcal enterotoxin A (SEA) gene is cloned into an oncolytic adenovirus vector to limit its proliferation and expression merely in prostate tumor cells, so as to achieve the purpose of targeting and killing prostate tumor cells; and the tumor-specific replicative adenovirus vector is regulated by a prostate-specific antigen promoter (PSAP) and the telomerase reverse transcriptase promoter, so as to carry a SEA gene fragment and to be named as SG504-SEA, which has both specific proliferation capacity in tumor cells and strong cytotoxic T lymphocyte (CTL) stimulating capacity.
机译:提供了一种以前列腺肿瘤为靶标的超抗原基因的表达,尤其是提供了一种表达超抗原基因的以前列腺癌为靶标的双调控溶瘤腺病毒的制备方法,属于基因治疗技术领域。根据该制备方法,利用基因工程技术,将葡萄球菌肠毒素A(SEA)基因克隆到溶瘤腺病毒载体中,限制其仅在前列腺肿瘤细胞中的增殖和表达,从而达到靶向杀伤前列腺的目的。肿瘤细胞所述肿瘤特异性复制腺病毒载体由前列腺特异性抗原启动子(PSAP)和端粒酶逆转录酶启动子调控,以携带SEA基因片段,并命名为SG504-SEA,兼具特异性增殖能力对肿瘤细胞有很强的细胞毒性T淋巴细胞(CTL)刺激能力。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号